Trial Profile
Xenon-inhalation: elimination of xenon and its effect on erythropoetin-levels in blood of healthy volunteers
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Xenon (Primary)
- Indications Unspecified
- Focus Pharmacodynamics
- Acronyms XEPO
- Sponsors RWTH Aachen University
- 30 Mar 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 25 Jul 2014 New trial record